A questionnaire survey on the diagnosis and treatment of Fabry nephropathy in clinical practice

• Váldodahkkit: Soo Jeong Choi (Dahkki), Su Hyun Kim (Dahkki), Min Sung Lee (Dahkki), Samel Park (Dahkki), Eunjung Cho (Dahkki), Seung Seok Han (Dahkki), Eun Sil Koh (Dahkki), Byung Ha Chung (Dahkki), Kyung Hwan Jeong (Dahkki), Eun Hui Bae (Dahkki), Eun Young Lee (Dahkki), Young Joo Kwon (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: The Korean Society of Nephrology, 2023-09-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Background Fabry nephropathy is characterized by a deficiency of lysosomal alpha-galactosidase A, which results in proteinuria and kidney disease. The ineffectiveness of enzyme replacement therapy (ERT) for severe kidney failure highlights the need for early detection and meaningful markers. However...